co.don
1999
FOUNDED
PUBLIC
STATUS
91-100
EMPLOYEES
CNWK
STOCK SYMBOL
$2.93
SHARE PRICE
(As of Friday Closing)
Description
co.don AG in cell breeding for the joint-preserving treatment of articular cartilage damage. The company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures and dental disorders.
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
ETR
Primary Office
- Warthestraße 21
- 14513 Teltow
- Germany
+49 03328 00000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore co.don’s full profile, request a free trial.
co.don Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.16 - $6.51 | $62.6M | $2.92 | -$0.49 | 22.9K | 21.4M |
co.don Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 96,431 | 70,680 | 154,857 | 42,653 |
| Revenue | 6,645 | 6,672 | 7,134 | 6,192 |
| EBITDA | (9,432) | (9,258) | (6,823) | (3,769) |
| Net Income | (9,819) | (7,400) | (7,418) | (4,037) |
| Total Assets | 29,050 | 31,367 | 23,688 | 5,070 |
| Total Debt | 2,989 | 10,849 | 668 | 628 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer